Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Zynex Inc (ZYXI)

Zynex Inc (ZYXI)
2.45 x 1 2.68 x 8
Post-market by (Cboe BZX)
2.52 +0.08 (+3.28%) 04/24/25 [NASDAQ]
2.45 x 1 2.68 x 8
Post-market 2.52 unch (unch) 16:01 ET
News & Headlines for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Why Zynex Plunged Today

Earnings and guidance disappointed, but the pullback could be an opportunity.

ZYXI : 2.52 (+3.28%)
Zynex Recognized in Top 100 Healthcare Technologies Companies for Second Year in a Row

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.52 (+3.28%)
Zynex, Inc Sets Third Quarter 2023 Earnings Call

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.52 (+3.28%)
Zynex to Present at the Cantor Global Healthcare Conference

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.52 (+3.28%)
Zynex Announces Share Repurchase Program

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.52 (+3.28%)
Zynex to Present at the H.C. Wainwright Global Investment Conference

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.52 (+3.28%)
Zynex Announces 1 Millionth Patient Milestone

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.52 (+3.28%)
Zynex, Inc Announces New Therapy Products

/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.52 (+3.28%)
Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET

/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.52 (+3.28%)
Zynex Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 2.52 (+3.28%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective